Warner Bros. Discovery, Inc.
QUINAZOLINE COMPOUND FOR EGFR INHIBITION
Last updated:
Abstract:
Disclosed is a novel quinazoline compound. Specifically, disclosed are a compound represented by the formula (I) and a pharmacologically acceptable salt. ##STR00001##
Status:
Application
Type:
Utility
Filling date:
29 Dec 2017
Issue date:
18 Jun 2020